During the past decade, Rush-Riverside Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rush-Riverside Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rush-Riverside Cancer Center" are "Leukemia" (2 trials), "Drug/Agent Toxicity by Tissue/Organ" (1 trials), "Myelodysplastic Syndromes" (1 trials) and "Neutropenia" (1 trials). Many other conditions were trialed in "Rush-Riverside Cancer Center" in a lesser frequency.

Most popular intervention types in "Rush-Riverside Cancer Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "amifostine trihydrate" (2 trials), "cytarabine" (2 trials), "mitoxantrone hydrochloride" (2 trials), "bromodeoxyuridine" (1 trials) and "idarubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rush-Riverside Cancer Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rush-Riverside Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rush-Riverside Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rush-Riverside Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".